Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/0239 stock hub

HKG/0239 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/0239is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

779.1M

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/0239

In the news

Latest news · HKG/0239

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E8.5

P25 10.7P50 17.9P75 38.5

ROE12.6

P25 -14.7P50 2P75 9.4

ROIC24.8

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/0239 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

HKD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Bermuda
Country code	HK
Employees	100
Employees Change	-6%
Employees Change Percent	-5.66
Enterprise value	HKD 433.7M
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	BMG6873Y1176
Last refreshed	2026-05-10
Market cap	HKD 779.1M
Price	HKD 2.5
Price currency	HKD
Rev Per Employee	2,142,800x
Sector	Healthcare
Sic	2834
Symbol	hkg/0239
Website	https://www.pakfahyeow.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	11.72%
EV Earnings	4.75x
EV/EBIT	3.94x
EV/EBITDA	3.7x
EV/Sales	2.02x
P/B ratio	1.08x
P/E ratio	8.53x
P/S ratio	3.64x
PE Ratio10 Y	11.1x
PE Ratio3 Y	9.38x
PE Ratio5 Y	8.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	51.31%
EBITDA Margin	54.76%
Gross margin	86.06%
Gross Profit	HKD 184.4M
Gross Profit Growth	6.32%
Gross Profit Growth Q	12.34%
Gross Profit Growth3 Y	-7.24%
Gross Profit Growth5 Y	1.69%
Net Income	HKD 91.3M
Net Income Growth	16.17%
Net Income Growth Q	65.28%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	-1.8%
Net Income Growth5 Y	0.71%
Pretax Margin	50.18%
Profit Margin	42.63%
Profit Per Employee	HKD 913,460
Profitable Years	5
ROA	8.22
Roa5y	6.92
ROCE	13.62
ROE	12.56
Roe5y	9.42
ROIC	24.76
Roic5y	16.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.92%
Cagr15y	5.48%
Cagr1y	17.48%
Cagr20y	10.16%
Cagr3y	30.45%
Cagr5y	13.89%
Div CAGR10	3.63%
Div CAGR3	17.39%
Div CAGR5	11.44%
EPS Growth	16.17
EPS Growth Q	65.28
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	-1.8
EPS Growth5 Y	0.71
Revenue Growth	-9.75x
Revenue Growth Q	14.09x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-6.93x
Revenue Growth5 Y	-0.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.26
Assets	HKD 828.4M
Cash	HKD 350.2M
Current Assets	HKD 388.4M
Current Liabilities	HKD 21.1M
Debt	HKD 4.8M
Debt EBITDA	HKD 0.04
Debt Equity	HKD 0.01
Equity	HKD 722.7M
Interest Coverage	201.4
Liabilities	HKD 105.6M
Long Term Assets	HKD 440M
Long Term Liabilities	HKD 84.5M
Net Cash	HKD 345.4M
Net Cash By Market Cap	HKD 44.34
Net Cash Growth	18.99%
Net Debt EBITDA	HKD -2.94
Net Debt Equity	HKD -0.48
Tangible Book Value	HKD 720.3M
Tangible Book Value Per Share	HKD 2.31
WACC	6.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.4
Inventory Turnover	2.42
Net Working Capital	HKD 21.8M
Quick ratio	17.8
Working Capital	HKD 367.3M
Working Capital Turnover	HKD 0.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-40.54%
Dividend Growth Years	0%
Dividend per share	HKD 0.19
Dividend Years	21
Dividend Yield	7.6%
Ex Div Date	2026-07-06
Last Dividend	HKD 0.11
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	9.56%
1Y total return	17.46%
200-day SMA	2.43
3Y total return	122.03%
50-day SMA	2.41
50-day SMA vs 200-day SMA	50under200
5Y total return	91.6%
All Time High	4.5
All Time High Change	-44.44%
All Time High Date	2015-07-02
All Time Low	0.05
All Time Low Change	4,487.16%
All Time Low Date	1992-12-03
ATR	0.02
Beta	0.41
Beta1y	0.16
Beta2y	-0.02
Ch YTD	5.49
High	2.5
High52	2.65
High52 Date	2025-07-04
High52ch	-5.66%
Low	2.5
Low52	2.14
Low52 Date	2025-05-08
Low52ch	17.48%
Ma50ch	3.61%
Price vs 200-day SMA	3.09%
RSI	65.04
RSI Monthly	60.46
RSI Weekly	59.2
Sharpe ratio	0.82x
Sortino ratio	1.6
Total Return	7.6%
Tr YTD	5.49
Tr15y	122.56%
Tr1m	4.17%
Tr3m	4.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 110M
Operating Income Growth	11.63
Operating Income Growth Q	23.09
Operating Income Growth3 Y	-9.91
Operating Income Growth5 Y	1.39
Operating margin	51.31

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	120,012,599%
Shares Insiders	41.43%
Shares Institutions	4.86%
Shares Out	311,640,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	19,950.5x
Bv Per Share	2.32
Ch10y	-35.57
Ch15y	1.34
Ch1m	4.17
Ch1y	9.17
Ch20y	108.3
Ch3m	4.17
Ch3y	72.41
Ch5y	35.14
Ch6m	1.63
Change	0%
Change From Open	0
Close	2.5
Days Gap	0
Depreciation Amortization	7,383,000
Dollar Volume	43,750
Earnings Date	2026-08-27
EBIT	HKD 110M
EBITDA	HKD 117.3M
EPS	HKD 0.29
F Score	4
Fiscal Year End	December
Founded	1,927
Graham Number	3.91089
Graham Upside	56.44
Income Tax	HKD 16.2M
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Last Split Date	2015-07-02
Last Split Type	Forward
Lynch Fair Value	HKD 1.47
Lynch Upside	-41.38
Ma150	2.42
Ma150ch	3.48%
Ma20	2.47
Ma20ch	1.05%
Next Earnings Date	2026-08-27
Open	2.5
Payment Date	2026-08-07
Ppne	431,556,000
Price Date	2026-05-08
Price EBITDA	HKD 6.64
Ptbv Ratio	1.08
Relative Volume	0.92x
Revenue	214,280,000x
Tax By Revenue	7.55x
Tax Rate	15.05%
Tr20y	592.05%
Tr6m	1.63%
Volume	17,500

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/0239 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.6%

$0.19 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.4%

0 consecutive years of growth

Total shareholder yield

+7.6%

Next ex-dividend date: 2026-07-06

Performance

HKG/0239 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/0239?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.9%

Share of float held by funds and institutions

Insider ownership

+41.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/0239 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.0

Neutral momentum band

Price vs 200-day MA

+3.1%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

0.82

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/0239

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/0239 stock rating?

hkg/0239 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/0239 analysis?

The full report lives at /stocks/hkg/0239/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/0239?

The latest report frames hkg/0239 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/0239 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.